Media stories about Asante Solutions (NASDAQ:PUMP) have trended somewhat positive on Tuesday, Accern Sentiment Analysis reports. Accern identifies negative and positive media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Asante Solutions earned a coverage optimism score of 0.06 on Accern’s scale. Accern also gave headlines about the company an impact score of 45.9518691870133 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
These are some of the news headlines that may have impacted Accern Sentiment’s scoring:
- Asante Solutions (PUMP) Coverage Initiated by Analysts at Stephens (americanbankingnews.com)
- FY2018 EPS Estimates for Asante Solutions Inc (PUMP) Increased by Analyst (americanbankingnews.com)
- Asante Solutions (PUMP) Downgraded to Hold at Zacks Investment Research (americanbankingnews.com)
- Asante Solutions (PUMP) Upgraded at Zacks Investment Research (americanbankingnews.com)
- FY2017 EPS Estimates for Asante Solutions Inc (PUMP) Raised by Analyst (americanbankingnews.com)
Several research firms have recently issued reports on PUMP. Stephens began coverage on Asante Solutions in a research note on Tuesday. They issued an “overweight” rating for the company. Barclays reissued a “hold” rating and issued a $18.00 price target on shares of Asante Solutions in a research note on Friday, November 10th. Credit Suisse Group increased their price target on Asante Solutions from $17.00 to $20.00 and gave the stock an “outperform” rating in a research note on Friday, November 3rd. BidaskClub raised Asante Solutions from a “hold” rating to a “buy” rating in a research note on Thursday, September 28th. Finally, Zacks Investment Research raised Asante Solutions from a “hold” rating to a “strong-buy” rating and set a $23.00 target price for the company in a research note on Friday. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $20.85.
Asante Solutions (NASDAQ:PUMP) last announced its earnings results on Wednesday, November 1st. The company reported $0.25 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.20 by $0.05. The firm had revenue of $282.70 million for the quarter, compared to the consensus estimate of $261.69 million. The firm’s quarterly revenue was up 32.4% compared to the same quarter last year.
In other news, major shareholder Energy Capital Partners Ii, Ll sold 13,800,000 shares of the company’s stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $15.07, for a total transaction of $207,966,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
COPYRIGHT VIOLATION WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Impact Asante Solutions (PUMP) Stock Price” was originally published by Community Financial News and is owned by of Community Financial News. If you are viewing this story on another site, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this story can be accessed at https://www.com-unik.info/2018/01/09/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-asante-solutions-pump-stock-price.html.
About Asante Solutions
Asante Solutions, Inc is a medical device company. The Company is a manufacturer of Asante Snap Insulin Pump System (Snap system), which is a pump featuring a modular design with pre-filled insulin cartridges and disposable pump bodies, utilized in combination with a controller. The Snap system comprises four components: the Snap system controller, a disposable pump body, disposable pre-filled insulin cartridges and disposable infusion sets.
Receive News & Ratings for Asante Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asante Solutions and related companies with MarketBeat.com's FREE daily email newsletter.